Sinopharm Group (SHTDY) Short Interest Ratio & Short Volume $12.36 -0.26 (-2.06%) As of 03:50 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartDividendFinancialsHeadlinesShort Interest Sinopharm Group Short Interest DataSinopharm Group (SHTDY) has a short interest of 4,500 shares. This marks a -26.23% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 14,439 shares to cover all short positions.Current Short Interest4,500 sharesPrevious Short Interest6,100 sharesChange Vs. Previous Month-26.23%Dollar Volume Sold Short$55,125.00Short Interest Ratio0.2 Days to CoverLast Record DateFebruary 28, 2025Today's Trading Volume26,120 sharesAverage Trading Volume14,439 sharesToday's Volume Vs. Average181% Short Selling Sinopharm Group? Sign up to receive the latest short interest report for Sinopharm Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSHTDY Short Interest Over TimeSHTDY Days to Cover Over TimeSHTDY Percentage of Float Shorted Over Time Remove Ads Sinopharm Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/20254,500 shares $55,125.00 -26.2%N/A0.2 $12.25 2/15/20256,100 shares $77,592.00 +79.4%N/A0.2 $12.72 1/31/20253,400 shares $45,016.00 -84.4%N/A0.1 $13.24 1/15/202521,800 shares $281,874.00 +113.7%N/A0.6 $12.93 12/31/202410,200 shares $138,414.00 +2.0%N/A0.5 $13.57 12/15/202410,000 shares $140,260.00 +56.3%N/A0.4 $14.03 11/30/20246,400 shares $86,598.40 +6.7%N/A0.3 $13.53 11/15/20246,000 shares $77,940.00 -90.5%N/A0.2 $12.99 10/31/202463,200 shares $785,260.00 +305.1%N/A0.8 $12.43 10/15/202415,600 shares $195,234.00 +642.9%N/A0.7 $12.52 Get the Latest News and Ratings for SHTDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter. 9/30/20242,100 shares $27,520.50 +2,000.0%N/A0 $13.11 9/15/2024100 shares $1,061.00 -97.6%N/A0 $10.61 8/31/20244,200 shares $48,472.20 +1,300.0%N/A0.2 $11.54 8/15/2024300 shares $3,805.65 +200.0%N/A0 $12.69 7/31/2024100 shares $1,161.00 -66.7%N/A0 $11.61 7/15/2024300 shares $3,705.00 +50.0%N/A0 $12.35 6/30/2024200 shares $2,646.00 -89.5%N/A0 $13.23 6/15/20241,900 shares $26,531.60 +46.2%N/A0.1 $13.96 5/31/20241,300 shares $17,654.00 -93.7%N/A0.1 $13.58 5/15/202420,700 shares $299,943.00 -17.2%N/A1.2 $14.49 4/30/202425,000 shares $313,500.00 +7.8%N/A1.1 $12.54 4/15/202423,200 shares $288,202.00 -22.4%N/A1.2 $12.42 3/31/202429,900 shares $382,421.00 +33.5%N/A1.7 $12.79 3/15/202422,400 shares $296,340.80 +2.3%N/A1.7 $13.23 2/29/202421,900 shares $304,519.50 +356.3%N/A0.9 $13.91 2/15/20244,800 shares $63,336.00 -66.7%N/A0.1 $13.20 1/15/202493,500 shares $1.22 million +15.7%N/A3.1 $13.03 12/31/202380,800 shares $1.05 million +49.1%N/A1.1 $13.05 12/15/202354,200 shares $662,324.00 +100.0%N/A1.3 $12.22 11/30/202327,100 shares $333,601.00 -44.6%N/A0.3 $12.31 11/15/202348,900 shares $615,651.00 +0.8%N/A1.8 $12.59 10/31/202348,500 shares $574,725.00 -23.1%N/A1.4 $11.85 10/15/202363,100 shares $891,129.75 -8.6%N/A3 $14.12 9/30/202369,000 shares $1.00 million +1.6%N/A2.4 $14.52 9/15/202367,900 shares $943,810.00 +9.5%N/A2.8 $13.90 8/31/202362,000 shares $901,480.00 +166.1%N/A1.4 $14.54 8/15/202323,300 shares $312,220.00 +47.5%N/A0.8 $13.40 7/31/202315,800 shares $247,546.50 -21.4%N/A0.6 $15.67 7/15/202320,100 shares $299,590.50 +9.8%N/A0.9 $14.91 6/30/202318,300 shares $284,565.00 +120.5%N/A0.6 $15.55Magnificent 7 wipeout: What's next? (Ad)A massive wave of volatility is sweeping the stock market... After the recent selloff, the "Magnificent Seven" stocks are now down over 10% on average over the past month. People are nervous...The short answer: Follow the man I've had the pleasure of working with over the past several years. 6/15/20238,300 shares $135,207.00 No ChangeN/A0.1 $16.29 5/15/20232,300 shares $38,916.00 -45.2%N/A0.1 $16.92 4/30/20234,200 shares $73,542.00 -30.0%N/A0.3 $17.51 4/15/20236,000 shares $94,140.00 +81.8%N/A0.3 $15.69 3/31/20233,300 shares $49,137.00 -84.9%N/A0 $14.89 3/15/202321,900 shares $301,125.00 +90.4%N/A1.1 $13.75 2/28/202311,500 shares $153,697.50 +62.0%N/A0.9 $13.37 2/15/20237,100 shares $97,270.00 -78.1%N/A0.3 $13.70 1/31/202332,400 shares $393,984.00 +14.5%N/A1.6 $12.16 1/15/202328,300 shares $364,787.00 +126.4%N/A0.7 $12.89 12/30/202212,500 shares $157,375.00 -40.2%N/A0.4 $12.59 12/15/202220,900 shares $270,655.00 +194.4%N/A0.5 $12.95 11/30/20227,100 shares $83,993.00 -43.7%N/A0.2 $11.83 11/15/202212,600 shares $137,970.00 -76.8%N/A0.1 $10.95 10/31/202254,300 shares $512,592.00 +1,408.3%N/A0.5 $9.44 10/15/20223,600 shares $36,396.00 +20.0%N/A0 $10.11 9/30/20223,000 shares $29,730.00 +328.6%N/A0 $9.91 9/15/2022700 shares $7,105.00 -91.3%N/A0 $10.15 8/31/20228,000 shares $88,560.00 -51.2%N/A0.1 $11.07 8/15/202216,400 shares $181,220.00 +2,242.9%N/A0.3 $11.05 7/31/2022700 shares $8,015.00 -92.2%N/A0 $11.45 7/15/20229,000 shares $106,560.00 -62.3%N/A0.2 $11.84 6/30/202223,900 shares $288,712.00 +23,800.0%N/A0.4 $12.08 6/15/2022100 shares $1,160.00 -93.3%N/A0 $11.60 5/31/20221,500 shares $18,390.00 -6.3%N/A0 $12.26 5/15/20221,600 shares $18,496.00 -5.9%N/A0 $11.56 4/30/20221,700 shares $19,286.50 -51.4%N/A0 $11.35 4/15/20223,500 shares $38,675.00 -70.1%N/A0.1 $11.05 3/31/202211,700 shares $132,151.50 +4.5%N/A0.2 $11.30 3/15/202211,200 shares $119,728.00 +100.0%N/A0.1 $10.69 2/28/20225,600 shares $68,040.00 -3.5%N/A0.1 $12.15 2/15/20225,800 shares $71,688.00 -94.5%N/A0.1 $12.36 1/31/2022105,500 shares $1.19 million -27.1%N/A0.8 $11.28 1/15/2022144,700 shares $1.70 million +460.9%N/A0.8 $11.73 12/31/202125,800 shares $278,898.00 No ChangeN/A0.2 $10.81 11/30/20211,900 shares $20,501.00 -83.6%N/A0 $10.79 11/15/202111,600 shares $131,776.00 +866.7%N/A0.2 $11.36 10/29/20211,200 shares $14,196.00 -88.2%N/A0 $11.83 10/15/202110,200 shares $137,190.00 +292.3%N/A0.2 $13.45 9/30/20212,600 shares $33,845.50 +30.0%N/A0.1 $13.02 9/15/20212,000 shares $26,260.00 -73.0%N/A0 $13.13 8/31/20217,400 shares $94,350.00 -23.7%N/A0.2 $12.75 8/13/20219,700 shares $131,629.00 +76.4%N/A0.3 $13.57 7/30/20215,500 shares $71,995.00 -42.7%N/A0.1 $13.09 7/15/20219,600 shares $139,296.96 +585.7%N/A0.2 $14.51 6/30/20211,400 shares $20,874.00 -50.0%N/A0 $14.91 6/15/20212,800 shares $42,868.00 +27.3%N/A0.1 $15.31 5/28/20212,200 shares $36,608.00 -91.7%N/A0.1 $16.64 5/14/202126,600 shares $424,270.00 +6,550.0%N/A0.4 $15.95 4/30/2021400 shares $6,140.00 -88.2%N/A0 $15.35Magnificent 7 wipeout: What's next? (Ad)A massive wave of volatility is sweeping the stock market... After the recent selloff, the "Magnificent Seven" stocks are now down over 10% on average over the past month. People are nervous...The short answer: Follow the man I've had the pleasure of working with over the past several years. 4/15/20213,400 shares $45,084.00 +3,300.0%N/A0 $13.26 3/31/2021100 shares $1,213.00 No ChangeN/A0 $12.13 2/26/20217,400 shares $87,838.00 +516.7%N/A0.1 $11.87 2/12/20211,200 shares $14,767.68 -60.0%N/A0 $12.31 1/29/20213,000 shares $37,650.00 -91.5%N/A0 $12.55 1/15/202117,400 shares $207,582.00 -4.9%N/A0.2 $11.93 12/31/202014,600 shares $171,842.00 -16.1%N/A0.1 $11.77 12/15/202017,400 shares $211,758.00 -4.9%N/A0.2 $12.17 11/30/202018,300 shares $232,410.00 +110.3%N/A0.3 $12.70 11/15/20208,700 shares $106,401.00 No ChangeN/A0.2 $12.23 10/15/202021,900 shares $236,082.00 +30.4%N/A0.6 $10.78 9/30/202016,800 shares $177,408.00 +16,700.0%N/A0.5 $10.56 9/15/2020100 shares $1,213.00 -99.5%N/A0 $12.13 8/31/202021,100 shares $259,952.00 +3,416.7%N/A0.4 $12.32 8/14/2020600 shares $7,245.60 +500.0%N/A0 $12.08 7/31/2020100 shares $1,180.50 -97.6%N/A0 $11.81 7/15/20204,100 shares $50,758.00 +127.8%N/A0.1 $12.38 6/30/20201,800 shares $22,806.00 +350.0%N/A0 $12.67 6/15/2020400 shares $4,872.00 +33.3%N/A0 $12.18 5/29/2020300 shares $3,674.25 -40.0%N/A0 $12.25 5/15/2020500 shares $6,135.00 -97.1%N/A0 $12.27 4/30/202017,500 shares $232,400.00 +98.9%N/A0.1 $13.28 4/15/20208,800 shares $111,144.00 -72.9%N/A0.2 $12.63 3/31/202032,500 shares $360,100.00 +62.5%N/A0.2 $11.08 3/13/202020,000 shares $246,000.00 -9.1%N/A0.4 $12.30 SHTDY Short Interest - Frequently Asked Questions What is Sinopharm Group's current short interest? Short interest is the volume of Sinopharm Group shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 4,500 shares of SHTDY short. Learn More on Sinopharm Group's current short interest. Is Sinopharm Group's short interest increasing or decreasing? Sinopharm Group saw a drop in short interest in the month of February. As of February 28th, there was short interest totaling 4,500 shares, a drop of 26.2% from the previous total of 6,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sinopharm Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "personal services" compare to Sinopharm Group: Roche Holding AG (0.18%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Sinopharm Group stock? Short selling SHTDY is an investing strategy that aims to generate trading profit from Sinopharm Group as its price is falling. SHTDY shares are trading down $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sinopharm Group? A short squeeze for Sinopharm Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SHTDY, which in turn drives the price of the stock up even further. How often is Sinopharm Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SHTDY, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies Aalberts Short Interest Data Absa Group Short Interest Data Air China Short Interest Data Airbus Short Interest Data Airports of Thailand Public Short Interest Data Akbank T.A.S. Short Interest Data Amada Short Interest Data Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi Short Interest Data Asia Broadband Short Interest Data ATEX Resources Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SHTDY) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | SponsoredElon Refuses to Pay a DividendElon Musk refuses to pay a Tesla dividend. But thanks to a new investment breakthrough… You could start ...Investors Alley | SponsoredTrumps Tariffs Are Fueling This (collect your share)Trump's new tariffs are shaking up the economy—raising prices, disrupting industries, and forcing businesses t...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinopharm Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SHTDY Stock Alerts